Benzinga · Sep 1, 2026
Wells Fargo Maintains Overweight on CareTrust REIT, Lowers Price Target to $44
Wells Fargo analyst John Kilichowski maintains CareTrust REIT (NYSE:CTRE) with a Overweight and lowers the price target from $47 to $44.
CT
NYSE · CTRE
CareTrust REIT, Inc.
Real Estate · REIT - Healthcare Facilities
$38.82
Down-$0.22 (-0.56%)
Updated Sep 11, 2026, 10:55 AM
SID Score
5.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 6.94B
- P/E ratio
- 29.07
- Dividend yield
- 3.34%
- 52-week range
- $35.65 – $43.62
- Volume
- 1.63M
- Avg. volume
- 1.95M
Price performance
CTRE price history
1M range · 0 trading sessions · Daily adjusted prices
CTRE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest CTRE news
The latest Smart Investors Daily articles mentioning CTRE.
Stock researchCompany · Overview
CTRE research
Overview
Company profile and research snapshot.
Company profile
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $39.25
- Implied upside
- —
- Analysts
- 16
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 1, 2026 | Wells Fargo | Overweight | — |
| Aug 14, 2026 | RBC Capital | Sector Perform | — |
| Aug 10, 2026 | Cantor Fitzgerald | Neutral | — |
| Jun 17, 2026 | Raymond James | Outperform | — |
| Jun 15, 2026 | BMO Capital | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 28, 2026
Could CareTrust (CTRE) Stock Be a Top Healthcare REIT as Acquisition Growth Accelerates?
CareTrust REIT, Inc. (NYSE:CTRE) caught market attention after delivering strong fiscal Q2 2026 operating results and raising its full-year 2026 guidance. The healthcare REIT now expects full-year normalized FFO per share of $2.03 to $2.06, placing the midpoint right in line with the $2.03 analyst consensus. For Q2 2026, CareTrust reported total revenues of $161.34 […]
Yahoo · Aug 26, 2026
FVR vs. CTRE: Which Stock Is the Better Value Option?
FVR vs. CTRE: Which Stock Is the Better Value Option?
SeekingAlpha · Aug 18, 2026
CareTrust: Buy The Dip On This Income And Growth Machine
CareTrust's diversified platform, robust pipeline, and focus on quality operators underpin 16% FFO/share growth guidance for 2026. See why CTRE is a Buy.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
